• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

AI Detects Brain Tumors Smaller Than a Grain of Rice — With 97% Accuracy

by Fred Pennic 06/27/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Robovision Healthcare and the Netherlands Cancer Institute (NKI) have unveiled a pioneering AI solution, BrainMets AI, capable of detecting brain metastatic disease with unprecedented precision. The breakthrough research, published in Radiology, the flagship journal of the Radiological Society of North America (RSNA), promises earlier detection, potentially improving outcomes for millions of cancer patients.

– Every year, countless cancer patients face the devastating reality that their disease has silently spread to the brain. These tiny metastases, some no larger than a grain of rice, frequently evade even the most experienced radiologists due to their minuscule size and the sheer volume of MRI data. BrainMets AI aims to change this, offering a powerful new ally in the fight against cancer.

Why Early Detection of Brain Metastases Matters

Brain metastases are the most common tumors in the central nervous system, affecting up to 17% of adult cancer patients. Early detection is not just beneficial, it’s critical. These lesions can grow rapidly, complicating treatment options and leading to severe neurological complications. The challenge for radiologists is immense: MRI scans, particularly of the brain, generate hundreds of slices per patient, making it incredibly difficult to identify lesions smaller than 3mm, which are often missed even in high-volume, top-tier centers.

Introducing BrainMets AI: A New Standard in Neuroradiology

BrainMets AI, developed by Robovision Healthcare in close collaboration with the NKI, has demonstrated remarkable accuracy. The AI solution achieved an astounding 97.4% lesion-level sensitivity, including an impressive 93.3% sensitivity on sub-3mm lesions. In an external validation set of 260 patients, the model successfully identified every single scan with brain metastases, yielding zero false negatives and fewer than 2 percent false positives.

“Like any recipe, the quality of AI comes from the quality of the ingredients and the skill of the chef,” said Stephane Willaert, Head of Robovision Healthcare. “With meticulously curated data, accurate annotations, and an optimized neural network architecture from Robovision, we were able to create an algorithm that sets a new standard in neuroradiology.”

The rigorous methodology underpinning this achievement included:

  • A diverse, expertly annotated dataset comprising over 1,500 MRI cases from multiple institutions across Europe and the USA.
  • High-fidelity voxel-level annotations performed by neuroradiology specialists.
  • A custom model architecture developed in-house by Robovision’s dedicated AI team.

Reducing Workflow Burdens and Enhancing Diagnostic Confidence

BrainMets AI is currently undergoing clinical validation trials across Europe, with testing also underway in the United States. Poised to become commercially available by 2026, pending CE and FDA clearance, this concurrent reading aid seamlessly integrates into existing clinical workflows. Beyond its superior detection capabilities, BrainMets AI offers quantification, segmentation, and longitudinal tracking, significantly reducing documentation burden for radiologists.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |